Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Borgel

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Molecular Cancer Therapeutics|July 9, 2009
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionAnnamaria Rapisarda, Melinda Hollingshead, Badarch Uranchimeg, et al.
Thrombosis and Haemostasis|December 29, 2000
Protein S deficiency: a database of mutations--summary of the first updateS Gandrille, D Borgel, N Sala, et al.
Thrombosis and Haemostasis|June 1, 1997
Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisS Gandrille, D Borgel, H Ireland, et al.
BMC Genomics|June 3, 2014
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studiesMelinda G Hollingshead, Luke H Stockwin, Sergio Y Alcoser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer modelsLyuba Varticovski, Melinda G Hollingshead, Ana I Robles, et al.
Nature Medicine|August 9, 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Cancer Therapeutics|July 9, 2009
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionAnnamaria Rapisarda, Melinda Hollingshead, Badarch Uranchimeg, et al.
Thrombosis and Haemostasis|December 29, 2000
Protein S deficiency: a database of mutations--summary of the first updateS Gandrille, D Borgel, N Sala, et al.
Thrombosis and Haemostasis|June 1, 1997
Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisS Gandrille, D Borgel, H Ireland, et al.
BMC Genomics|June 3, 2014
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studiesMelinda G Hollingshead, Luke H Stockwin, Sergio Y Alcoser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer modelsLyuba Varticovski, Melinda G Hollingshead, Ana I Robles, et al.
Nature Medicine|August 9, 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Pageof 4